Title |
Docking and dynamic simulation study of Crizotinib and Temozolomide drug with Glioblastoma and NSCLC target to identify better efficacy of the drug
|
---|---|
Published in |
Future Journal of Pharmaceutical Sciences, September 2021
|
DOI | 10.1186/s43094-021-00323-2 |
Authors |
Saleena Younus, S. S. Vinod Chandra, Achuth Sankar S. Nair |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 14 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 3 | 21% |
Student > Doctoral Student | 2 | 14% |
Student > Master | 2 | 14% |
Student > Bachelor | 1 | 7% |
Professor > Associate Professor | 1 | 7% |
Other | 0 | 0% |
Unknown | 5 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 3 | 21% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 14% |
Unspecified | 1 | 7% |
Biochemistry, Genetics and Molecular Biology | 1 | 7% |
Environmental Science | 1 | 7% |
Other | 0 | 0% |
Unknown | 6 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2021.
All research outputs
#16,734,944
of 25,392,582 outputs
Outputs from Future Journal of Pharmaceutical Sciences
#38
of 96 outputs
Outputs of similar age
#247,834
of 433,770 outputs
Outputs of similar age from Future Journal of Pharmaceutical Sciences
#3
of 11 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 96 research outputs from this source. They receive a mean Attention Score of 3.5. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,770 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.